Even if adjuvant chemotherapy is given after surgery in these cases, a third-generation regimen (anthracycline/taxane based) may be avoided.
Before beginning preoperative therapy, the extent of the disease within the breast and regional lymph nodes should be assessed.
Staging of systemic disease may include:[6] Computed tomography scan of the chest and abdomen and a bone scan.
Positron emission tomography.
When breast-conserving therapy is desired, baseline breast imaging is performed to identify the tumor location and exclude multicentric disease.
Suspicious abnormalities are usually biopsied before beginning treatment, and a marker is placed at the center of the breast tumor(s).